Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Here’s an interesting addition to your biotechnology-sector holdings: California-headquartered Progenity (NASDAQ: PROG ) develops targeted therapeutics for diseases, and traders should be glad to know that...
Shares of Progenity (NASDAQ: PROG) were up more than 34% on Tuesday. At the time of its initial public offering in 2020, the biotech company went for $13 a share, and the stock has been highly volatile because it is a retail investor favorite. The stock closed at $3.47 a share on Mo...
Gainers: BIMI International Medical (NASDAQ:BIMI) +55%. Kezar Life Sciences (NASDAQ:KZR) +31%. CNS Pharmaceuticals (NASDAQ:CNSP) +28%. ReTo Eco-Solutions (NASDAQ:RETO) +28%. Progenity (NASDAQ:PROG) +27%. PLBY Group (NASDAQ:PLBY) +27%. IonQ (NYSE:IONQ) +25%. Kuke (NYSE:KUKE) +21%. On Holding (...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips This season has highlighted Progenity (NASDAQ: PROG ) as a top short squeeze play. The biotech company focuses on improving diagnostic and treatment options available to healthcare providers, in turn improving the q...
The shares of San Diego, California-based Progenity (PROG +23.6%) have reached the highest level since early April as social media interest in the small-cap biotech has gained momentum. According to sites that track mentions of stocks on social media platforms, Progenity (NASDAQ:PROG) had mai...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips You can make money playing penny shares like Progenity (NASDAQ: PROG ) stock. Just get out while the getting is good. Source: PopTika / Shutterstock.com Progenity stock has been subject to a short squeeze since ...
Gainers: Kezar Life Sciences KZR +36%, Progenity (NASDAQ:PROG) +28%, GeoVax Labs GOVX +15%, Medicenna Therapeutics (NASDAQ:MDNA) +15%, Amarin AMRN +10%. Losers: Talkspace TALK -37%, OptiNose OPTN -34%, Molecular Partners MOLN...
If you’re looking for penny stocks to buy right now, I’m sure you’ve looked at some of the hot trends in the stock market today. We’ve discussed plenty of them in November too. Whether it’s the latest round of short squeeze penny stocks, meme stocks, popul...
Kezar Life Sciences (NASDAQ:KZR) +46% on phase 2 data for lupus candidate Axon Enterprise (NASDAQ:AXON) +24% on Q3 results Cyclo Therapeutics (NASDAQ:CYTH) +19% on Q3 results. Comstock Holding Companies (NASDAQ:CHCI) +20% on Q3 results. Romeo Power (NYS...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Progenity (NASDAQ: PROG ) is a biotech firm focused on treatments and testing products for a variety of diseases. Historically, PROG stock has been a disappointment. Since its initial public offering (IPO) in 2020, sh...
News, Short Squeeze, Breakout and More Instantly...
Progenity Inc. Company Name:
PROG Stock Symbol:
NASDAQ Market:
Pharmacokinetic and tissue data confirm NaviCap platform delivers topically through the entire colon, with lower systemic concentrations, as desired Data modeling suggests tofacitinib tissue concentrations greater than IC90 through at least 16 hours after dosing SAN DIEGO, July 18...
SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced further details on its virtual event to be held on Wednesday, July 17, 2024. The event will feature Bruce Sands, MD, MS (Icahn School of ...
Drug-device combination leverages Biora’s NaviCap ™ platform to deliver tofacitinib directly to colonic tissue as a potential treatment for ulcerative colitis BT-600 was well tolerated and met all trial objectives, demonstrating the NaviCap platform’s ab...